Doctors' Vet-Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 9.90 Cr
as on 18-07-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.04 Cr
as on 18-07-2024
- Satisfied Charges ₹ 1.14 Cr
as on 18-07-2024
- Revenue 11.47%
(FY 2023)
- Profit -21.11%
(FY 2023)
- Ebitda 18.26%
(FY 2023)
- Net Worth 3.78%
(FY 2023)
- Total Assets 6.72%
(FY 2023)
About Doctors' Vet-Pharma
The Corporate was formerly known as Doctors' Wet-Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.90 Cr.
The company currently has active open charges totaling ₹37.04 Cr. The company has closed loans amounting to ₹1.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sree Tulabandula, Chalamaiah Thulabandula, and Subbaiah Dudi serve as directors at the Company.
- CIN/LLPIN
U24231TG2000PTC035809
- Company No.
035809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Doctors' Vet-Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sree Tulabandula  | Director | 04-Dec-2000 | Current |
| Chalamaiah Thulabandula | Director | 01-Apr-2005 | Current |
| Subbaiah Dudi | Director | 04-Dec-2000 | Current |
Financial Performance of Doctors' Vet-Pharma.
Doctors' Vet-Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.47% increase. The company also saw a substantial fall in profitability, with a 21.11% decrease in profit. The company's net worth moved up by a moderate rise of 3.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctors' Vet-Pharma?
In 2023, Doctors' Vet-Pharma had a promoter holding of 76.85% and a public holding of 23.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doctor's Life Sciences (India) LimitedActive 17 years 7 monthsSree Tulabandula and Chalamaiah Thulabandula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Mar 2024 | ₹2.00 Cr | Open |
Others Creation Date: 18 Aug 2023 | ₹0.84 M | Open |
State Bank Of India Creation Date: 20 Feb 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Doctors' Vet-Pharma?
Unlock and access historical data on people associated with Doctors' Vet-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctors' Vet-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctors' Vet-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
